Effect of various clinical variables on total intracellular magnesium in hospitalized normomagnesemic diabetic patients before discharge

Biological Trace Element Research

Volumn 120, Issue 1-3, 2007, Pages 102-109

  Gorelik, Oleg ^a   Efrati, Shai ^a   Berman, Sylvia ^a   Almoznino Sarafian, Dorit ^a   Alon, Irena ^a   Shteinshnaider, Miriam ^a   Cohen, Natan ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Diabetes mellitus; Insulin; Intracellular magnesium; Metformin

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; MAGNESIUM; METFORMIN; NITRATE; PROTON PUMP INHIBITOR; ROSIGLITAZONE; SULFONYLUREA;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; COMORBIDITY; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL;

ADULT; AGED; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HOSPITALIZATION; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INTRACELLULAR FLUID; LEUKOCYTES, MONONUCLEAR; MAGNESIUM; MALE; MIDDLE AGED;

EID: 36049027415     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12011-007-8024-4     Document Type: Article

References (24)

1. Garland HO (1992) New experimental data on the relationship between diabetes mellitus and magnesium. Magnes Res 5:193-202
2. Resnick LM, Altura BT, Gupta RK, Laragh JH, Alderman MH, Altura BM (1993) Intracellular and extracellular magnesium depletion in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36:767-770
3. Tosiello L (1996) Hypomagnesemia and diabetes mellitus: a review of clinical implications. Arch Intern Med 156:1143-1148
4. de Lordes Lima M, Cruz T, Pousada JC, Rodrigues LE, Barbosa K, Cangucu V (1998) The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 21:682-686
5. Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A (2000) Magnesium: an update on physiological, clinical and analytical aspects. Clin Chim Acta 294:1-26
6. Paolisso G, Barbagallo M (1997) Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Am J Hypertens 10:346-355
7. Barbagallo M, Dominguez LJ (2007) Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys 458:40-47
8. Alzaid AA, Dinneen SF, Moyer TP, Rizza RA (1995) Effects of insulin on plasma magnesium in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab 80:1376-1381
9. Ryzen E, Elkayam U, Rude RK (1986) Low blood mononuclear cell magnesium in intensive cardiac care unit patients. Am Heart J 111:475-480
10. Reinhart RA, Marx JJ Jr, Haas RG, Desbiens NA (1987) Intracellular magnesium of mononuclear cells from venous blood of clinically healthy subjects. Clin Chim Acta 167:187-195
11. Reinhart RA (1988) Magnesium metabolism: a review with special reference to the relationship between intracellular content and serum levels. Arch Intern Med 148:2415-2420
12. Douban S, Brodsky MA, Whang DD, Whang R (1996) Significance of magnesium in congestive heart failure. Am Heart J 132:664-671
13. ++ and proliferative responsiveness of peripheral blood mononuclear cells from patients on chronic hemodialysis. Metabolism 50:270-276
14. Alon I, Berman S, Shteinshnaider M, Efrati S, Gorelik O, Almoznino-Sarafian D, Weissgarten J, Cohen N (2006) Total cellular calcium and magnesium content of cultured human peripheral blood mononuclear cells following exposure to antidiabetic drugs. Acta Diabetol 43:46-51
15. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
16. Dixon WJ (ed) (1993) BMDP statistical software. University of California Press, Los Angeles, California
17. Sjogren A, Floren CH, Nilsson A (1988) Magnesium, potassium and zinc deficiency in subjects with type II diabetes mellitus. Acta Med Scand 224:461-466
18. Delva P, Degan M, Pastori C, Faccini G, Lechi A (2002) Glucose-induced alterations of intracellular ionized magnesium in human lymphocytes. Life Sci 71:2119-2135
19. Sjogren A, Floren CH, Nilsson A (1986) Magnesium deficiency in IDDM related to level of glycosylated hemoglobin. Diabetes 35:459-463
20. Ewis SA, Abdel-Rahman MS (1995) Effect of metformin on glutathione and magnesium in normal and streptozotocin-induced diabetic rats. J Appl Toxicol 15:387-390
21. Ewis SA, Abdel-Rahman MS (1997) Influence of atenolol and/or metformin on glutathione and magnesium levels in diabetic rats. J Appl Toxicol 17:409-413
22. Matthaei S, Greten H (1991) Evidence that metformin ameliorates cellular insulin-resistance by potentiating insulin-induced translocation of glucose transporters to the plasma membrane. Diabetes Metab 17:150-158
23. Sjogren A, Floren CH, Nilsson A (1985) Measurements of magnesium in mononuclear cells. Sci Total Environ 42:77-82
24. Elin RJ (1988) Status of the determination of magnesium in mononuclear blood cells in humans. Magnesium 7:300-305